Peripheral, but not central effects of cannabidiol derivatives: Mediation by CB1 and unidentified receptors
- 30 June 2005
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 48 (8) , 1117-1129
- https://doi.org/10.1016/j.neuropharm.2005.01.023
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tractEuropean Journal of Pharmacology, 2003
- Cannabinoids for gastrointestinal diseases: potential therapeutic applicationsExpert Opinion on Investigational Drugs, 2003
- Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB1/CB2 receptorsEuropean Journal of Pharmacology, 2002
- Cannabinoids and Cystic FibrosisJournal of Cannabis Therapeutics, 2002
- Endocannabinoids in the central nervous system-an overviewProstaglandins, Leukotrienes & Essential Fatty Acids, 2002
- Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in miceBritish Journal of Pharmacology, 2001
- Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamideBritish Journal of Pharmacology, 2001
- Anandamides: tolerance and cross-tolerance toΔ9-tetrahydrocannabinolBrain Research, 1995
- Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituentEuropean Journal of Pharmacology, 1993
- The effect of cannabinoids on intestinal motility and their antinociceptive effect in miceBritish Journal of Pharmacology, 1973